CC-90011, a Potent, Oral, & Reversible LSD1 Inhibitor

Time: 11:00 am
day: Day Two


  • CC-90011, a potent, oral, and reversible LSD1 inhibitor, has been shown to be very well tolerated in patients
  • With follow-up as long as 44 cycles of treatment, no new AEs were identified; most TEAEs were mild, reversible, and easily manageable by short dose interruptions and dose modifications
  • Review early evidence of antitumor activity that was observed with CC- 90011 in some NENs and NHLs
  • Discuss how these data support further investigation of CC-90011 as a promising therapy